Puberty Suppressants Trial Debate
Full Debate: Read Full DebateEmily Darlington
Main Page: Emily Darlington (Labour - Milton Keynes Central)Department Debates - View all Emily Darlington's debates with the Department of Health and Social Care
(1 day, 20 hours ago)
Commons ChamberUrgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
I am grateful to the hon. Member for the way that she asks her question, as a critic of some of the decisions that I have taken in this space. The reassurance that I can offer is that the study will look at the holistic care that this group of children and young people receives, and ensure that wider evidence-led therapeutic support, including mental health support, is available, so that regardless of whether a young person receives puberty blockers, they will certainly receive that wider range of support.
Emily Darlington (Milton Keynes Central) (Lab)
I appreciate the science-based approach taken by the Secretary of State. We use puberty blockers for many different conditions, so will the trial look at the data that has been amassed from the use of puberty blockers for other conditions? I wish to state on the record that puberty blockers are reversible. The evidence shows that when people stop taking them, they stop working—that is the science behind them. Finally, young people in my constituency are more likely to age out of gender services than to get their first appointment, so what are we doing to shorten the waiting time, not just for puberty blockers but for the whole range of services provided to trans children by the NHS?